Comparison of Intranasal Dexmedetomidine Vs Midazolam for Premedication in Paediatric Patients Undergoing Elective Surgery
International Journal of Pharmaceutical Quality Assurance · 30.05.2026 · 17 (05)
DOI: 10.25258/ijpqa.17.5.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.05.2026. Verfasst von Nabanita Roy und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Preoperative anxiety is common in paediatric patients undergoing elective surgery and may adversely affect induction of anaesthesia, parental separation, and postoperative behaviour. Intranasal premedication is widely used due to its non-invasive and easy administration. Midazolam is traditionally used, but dexmedetomidine, an α2-adrenergic agonist, has emerged as an effective alternative with better sedation and anxiolysis and minimal respiratory depression. Aims and Objectives: To compare the efficacy and safety of intranasal dexmedetomidine versus intranasal midazolam as premedication in paediatric patients undergoing elective surgery. Materials and Methods: This prospective, randomized, comparative interventional study was conducted over 1 year at Dinhata Subdivisional Hospital, Coochbehar on 100 paediatric patients undergoing elective surgery under general anaesthesia. Patients were randomly assigned to receive either intranasal dexmedetomidine or midazolam, and outcomes including sedation, parental separation, mask acceptance, and adverse effects were compared.
Results
Baseline characteristics were comparable (age p = 0.912, gender p = 0.841). Dexmedetomidine showed significantly higher sedation scores at 30 min (3.80 ± 0.72 vs 3.10 ± 0.69) and 45 min (4.20 ± 0.55 vs 3.60 ± 0.60; p < 0.001), better parental separation (76% vs 50%; p = 0.018), and improved mask acceptance (72% vs 44%; p = 0.021), with fewer adverse effects overall (p = 0.014).
Conclusion
Intranasal dexmedetomidine is more effective than intranasal midazolam in providing sedation, anxiolysis, and smoother induction conditions in paediatric patients undergoing elective surgery, with a comparable safety profile. It can be considered a superior alternative for premedication in this population.
Zitieren
APA
Roy, N., & Chakrabarti, S. (2026). Comparison of Intranasal Dexmedetomidine Vs Midazolam for Premedication in Paediatric Patients Undergoing Elective Surgery. International Journal of Pharmaceutical Quality Assurance, 17(05). https://doi.org/10.25258/ijpqa.17.5.15
Vancouver
Roy N, Chakrabarti S. Comparison of Intranasal Dexmedetomidine Vs Midazolam for Premedication in Paediatric Patients Undergoing Elective Surgery. International Journal of Pharmaceutical Quality Assurance. 2026;17(05). doi:10.25258/ijpqa.17.5.15
BibTeX
@article{Roy2026,
author = {Roy, Nabanita and Chakrabarti, Souradeep},
title = {Comparison of Intranasal Dexmedetomidine Vs Midazolam for Premedication in Paediatric Patients Undergoing Elective Surgery},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {05},
doi = {10.25258/ijpqa.17.5.15}
}
EUVIMED